Nautilus Biotechnology to Present at TD Cowen Health Care Conference
Nautilus Biotechnology will participate in the TD Cowen 46th Annual Health Care Conference with a fireside chat on March 2, 2026. The event will be webcast live on the company's investor relations website.
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) will participate in the TD Cowen 46th Annual Health Care Conference, where management is scheduled to hold a fireside chat on Monday, March 2, 2026, at 10:30 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at www.nautilus.bio.
Nautilus, which is pioneering a single-molecule protein analysis platform, is a development stage life sciences company with corporate headquarters in Seattle, Washington and research and development headquarters in San Carlos, California. The company is working to create a platform technology for quantifying and unlocking the complexity of the proteome, with a mission to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine.